Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ARCA biopharma Inc announces pricing of $9 mln public offering of common stock and warrants

Tuesday, 4 Feb 2014 08:30am EST 

ARCA biopharma Inc:Says it has priced previously announced public offering of common stock and warrants at a price of $1.70 for each share of common stock and a related warrant to purchase 0.25 shares of common stock, for gross proceeds of $8.7 mln.Says the offering is expected to close on or about Feb. 7.Says the company intends to use the net proceeds of the offering for general corporate purposes, including working capital and operational purposes.Says Dawson James Securities, Inc. is acting as the sole book-running manager for the offering. 

Company Quote

-0.04 -3.51%
4:00pm EDT